GenMark Diagnostics Revenue 2010-2019 | GNMK

GenMark Diagnostics revenue from 2010 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
GenMark Diagnostics Annual Revenue
(Millions of US $)
2018 $71
2017 $53
2016 $49
2015 $39
2014 $31
2013 $27
2012 $20
2011 $5
2010 $3
2009 $1
GenMark Diagnostics Quarterly Revenue
(Millions of US $)
Q2 2019 $18
Q1 2019 $22
Q4 2018 $19
Q3 2018 $16
Q2 2018 $15
Q1 2018 $21
Q4 2017 $16
Q3 2017 $12
Q2 2017 $12
Q1 2017 $13
Q4 2016 $15
Q3 2016 $11
Q2 2016 $13
Q1 2016 $11
Q4 2015 $13
Q3 2015 $8
Q2 2015 $8
Q1 2015 $10
Q4 2014 $10
Q3 2014 $6
Q2 2014 $7
Q1 2014 $8
Q4 2013 $6
Q3 2013 $5
Q2 2013 $5
Q1 2013 $11
Q4 2012 $9
Q3 2012 $5
Q2 2012 $4
Q1 2012 $2
Q4 2011 $2
Q3 2011 $1
Q2 2011 $1
Q1 2011 $1
Q4 2010 $1
Q3 2010 $1
Q2 2010 $1
Q1 2010 $0
Q4 2009 $0
Q3 2009 $0
Q2 2009 $0
Q1 2009 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.369B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $109.454B 23.32
Intuitive Surgical (ISRG) United States $57.612B 50.39
Edwards Lifesciences (EW) United States $44.757B 43.56
IDEXX Laboratories (IDXX) United States $23.509B 58.98
Fresenius Medical Care AG KGaA (FMS) Germany $19.957B 13.22
Teleflex (TFX) United States $17.035B 36.16
Olympus (OCPNY) Japan $16.189B 121.13
SONOVA HOLDING (SONVY) Switzerland $14.665B 0.00
DexCom (DXCM) United States $14.456B 214.23
Hologic (HOLX) United States $13.317B 21.02
STERIS (STE) Ireland $12.870B 29.68
Sysmex ADR (SSMXY) Japan $12.420B 33.48
Varian Medical Systems (VAR) United States $9.773B 23.38
ABIOMED (ABMD) United States $8.715B 49.89
Masimo (MASI) United States $7.964B 48.32
SARTORIUS AG (SARTF) Germany $6.158B 54.71
Integra LifeSciences Holdings (IART) United States $5.135B 22.91
Penumbra (PEN) United States $5.054B 181.56
Elekta AB (EKTAY) Sweden $4.932B 39.35
Globus Medical (GMED) United States $4.827B 30.64
LivaNova (LIVN) United Kingdom $3.751B 28.60
Cantel Medical (CMD) United States $3.706B 37.59
Tandem Diabetes Care (TNDM) United States $3.350B 0.00
Wright Medical Group (WMGI) Netherlands $2.662B 233.44
Nihon Kohden (NHNKY) Japan $2.529B 25.45
Nevro (NVRO) United States $2.495B 0.00
Integer Holdings (ITGR) United States $2.473B 17.49
Glaukos (GKOS) United States $2.210B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.724B 31.97
Silk Road Medical (SILK) United States $1.230B 0.00
Veracyte (VCYT) United States $1.205B 0.00
OPKO Health (OPK) United States $1.170B 0.00
Natus Medical (NTUS) United States $1.031B 24.02
Accelerate Diagnostics (AXDX) United States $0.977B 0.00
CryoLife (CRY) United States $0.974B 92.79
ORTHOFIX MEDICAL INC (OFIX) United States $0.952B 29.89
Inogen (INGN) United States $0.940B 23.05
Tactile Systems Technology (TCMD) United States $0.924B 114.19
Luminex (LMNX) United States $0.921B 0.00
Corindus Vascular Robotics (CVRS) United States $0.889B 0.00
Pacific Biosciences Of California (PACB) United States $0.857B 0.00
Mesa Laboratories (MLAB) United States $0.852B 39.38
Quotient (QTNT) Switzerland $0.714B 0.00
AngioDynamics (ANGO) United States $0.699B 22.87
AxoGen (AXGN) United States $0.573B 0.00
Intersect ENT (XENT) United States $0.503B 0.00
OrthoPediatrics (KIDS) United States $0.464B 0.00
Si-Bone (SIBN) United States $0.457B 0.00
Fluidigm (FLDM) United States $0.443B 0.00
ViewRay (VRAY) United States $0.387B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.372B 14.29
Alphatec Holdings (ATEC) United States $0.343B 0.00
Sientra (SIEN) United States $0.316B 0.00
Semler Scientific (SMLR) United States $0.312B 52.75
Accuray (ARAY) United States $0.269B 0.00
IRadimed (IRMD) United States $0.239B 39.62
CRH Medical (CRHM) Canada $0.234B 81.25
RTI Surgical (RTIX) United States $0.222B 33.33
TransEnterix (TRXC) United States $0.207B 0.00
SeaSpine Holdings (SPNE) United States $0.204B 0.00
Neuronetics (STIM) United States $0.178B 0.00
Stereotaxis (STXS) United States $0.167B 0.00
ConforMIS (CFMS) United States $0.126B 0.00
Sensus Healthcare (SRTS) United States $0.104B 0.00
Second Sight Medical Products (EYES) United States $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.086B 0.00
Apollo Endosurgery (APEN) United States $0.069B 0.00
Ekso Bionics Holdings (EKSO) United States $0.063B 0.00
Spectral Diagnostics (EDTXF) Canada $0.062B 0.00
Helius Medical Technologies (HSDT) United States $0.052B 0.00
Vermillion (VRML) United States $0.052B 0.00
Electromed (ELMD) United States $0.044B 22.83
Xtant Medical Holdings (XTNT) United States $0.036B 0.00
T2 Biosystems (TTOO) United States $0.036B 0.00
Nuvectra (NVTR) United States $0.028B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.027B 0.00
Restoration Robotics (HAIR) United States $0.026B 0.00
Ra Medical Systems (RMED) United States $0.025B 0.00
ReWalk Robotics (RWLK) Israel $0.025B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
Bioanalytical Systems (BASI) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
Lianluo Smart (LLIT) China $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.015B 21.83
OBALON THERPTCS (OBLN) United States $0.014B 0.00
Dynatronics (DYNT) United States $0.012B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Avinger (AVGR) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Viveve Medical (VIVE) United States $0.006B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00